Y Griega CBD-20 by Medical Seeds Co
Indica strains × Sativa strains
Y Griega CBD 2.0 by Medical Seeds Co. is a hybrid strain developed to balance high CBD content with desirable aromatic and flavor profiles. It was created through meticulous breeding programs focused on therapeutic properties and a nuanced sensory experience.
Appearance
The buds of Y Griega CBD 2.0 are dense and well-formed, displaying a spectrum of colors from deep green to subtle purple hues. They are covered in abundant trichomes, giving them a frosted appearance that indicates a rich concentration of cannabinoids and terpenes.
The morphology is structured with compact calyxes and prominent pistils, creating intricate patterns. The buds often have a resinous look, suggesting a high quality and concentrated medicinal compound content.
Aroma & Flavor
The aroma is complex, starting with fresh citrus notes layered with subtle earthiness, hinting at its indica heritage. As the bud is handled, herbal, woody, and floral scents emerge, with users often detecting notes of lemongrass and pine.
The flavor profile mirrors the aroma, delivering a zesty lemon and lime taste on the inhale that transitions to an earthy and herbal palate on the exhale. Hints of pine and spice add to the well-rounded and engaging taste experience.
Effects
This strain is noted for providing a balanced experience, combining a calming sensation with uplifting cerebral effects. It is designed to offer therapeutic benefits without significant psychoactivity due to its cannabinoid profile.
Terpenes & Cannabinoids
Y Griega CBD 2.0 is characterized by a significant CBD content, typically ranging from 8% to 10%, with THC levels kept below 1%. This specific ratio is intended for users seeking the benefits of CBD without pronounced psychoactive effects.
The strain also contains trace amounts of other cannabinoids, such as CBG, which may contribute additional therapeutic properties. Its terpene profile is complex, contributing to its distinct aroma and flavor notes.
Origins & Lineage
Developed by Medical Seeds Co., Y Griega CBD 2.0 resulted from a desire to create a strain with maximized cannabidiol benefits while preserving complex flavor and effect profiles. It is a hybrid blend of indica and sativa strains, carefully selected for high CBD yields and balanced organoleptic properties.
The breeding process involved meticulous selection of parent lines with low THC expression and high CBD production, undergoing rigorous stability tests over multiple generations. This resulted in a genetically consistent strain with a balanced indica and sativa influence.